ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Clinical Trials Search


CurrentAll Trials


Trial Details

Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes from Recurrent Atrial Fibrillation

Design and Objective

A multi centre, randomised trial to determine if antral AF ablation without electrophysiological confirmation of PV isolation is more effective than anti-arrhythmic agents at achieving freedom from hospital based treatment.

Key inclusion criteria

1. Documented paroxysmal atrial fibrillation 2. Modification or initiation of anti-arrhythmic agent required for symptom control 3. Males or females eighteen (18) to eighty (80) years of age. 4. Suitable candidate for catheter ablation 5. Signed informed consent

Study Disclaimer Statement